This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 6, No 3 (2017): March

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain

Authors of this article:

Ian Gilron1 Author Orcid Image ;   Dongsheng Tu1 Author Orcid Image ;   Ronald Holden1 Author Orcid Image ;   Tanveer Towheed1 Author Orcid Image ;   Dan Ziegler2 Author Orcid Image ;   Louie Wang1 Author Orcid Image ;   Roumen Milev1 Author Orcid Image ;   Christopher Gray3 Author Orcid Image
Article Authors Cited by (5) Tweetations (4) Metrics

Journals

  1. Yao X, Li L, Kandhare A, Mukherjee‑Kandhare A, Bodhankar S. Attenuation of reserpine‑induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol. Experimental and Therapeutic Medicine 2019 View
  2. Hidaka S, Kanai Y, Takehana S, Syoji Y, Kubota Y, Uotsu N, Yui K, Shimazu Y, Takeda M. Systemic administration of α-lipoic acid suppresses excitability of nociceptive wide-dynamic range neurons in rat spinal trigeminal nucleus caudalis. Neuroscience Research 2019;144:14 View
  3. Gilron I, Tu D, Holden R, Towheed T, Vandenkerkhof E, Milev R. Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain. JMIR Research Protocols 2017;6(8):e154 View
  4. Schweiger V, Secchettin E, Castellani C, Martini A, Mazzocchi E, Picelli A, Polati E, Donadello K, Valenti M, Dalle Carbonare L. Comparison between Acupuncture and Nutraceutical Treatment with Migratens® in Patients with Fibromyalgia Syndrome: A Prospective Randomized Clinical Trial. Nutrients 2020;12(3):821 View
  5. Gilron I, Robb S, Tu D, Holden R, Towheed T, Ziegler D, Wang L, Milev R, Gray C. Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trial. Pain 2021;162(2):561 View